{
    "organizations": [],
    "uuid": "bce6b59325bbd2d19726d7d12564b76166544393",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vitrolife-hikes-dividend-q4-ebitda/brief-vitrolife-hikes-dividend-q4-ebitda-up-yr-yr-idUSFWN1PY0GR",
    "ord_in_thread": 0,
    "title": "BRIEF-Vitrolife hikes dividend, Q4 EBITDA up yr/yr",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Vitrolife Ab:\n* Q4 ‍SALES AMOUNTED TO SEK 271 (251) MILLION, CORRESPONDING TO AN INCREASE OF 8 PERCENT IN SEK​\n* Q4 ‍SALES GROWTH WAS 11 PERCENT IN LOCAL CURRENCY AND CONSISTED IN ITS ENTIRETY OF ORGANIC GROWTH.​\n* Q4 ‍OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 103 (96) MILLION, CORRESPONDING TO A MARGIN OF 38 (38) PERCENT​\n* SAYS ‍BOARD PROPOSES A DIVIDEND OF SEK 3.70 (2.60) PER SHARE​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ",
    "published": "2018-02-08T15:32:00.000+02:00",
    "crawled": "2018-02-09T16:42:50.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "vitrolife",
        "ab",
        "q4",
        "amounted",
        "sek",
        "million",
        "corresponding",
        "increase",
        "percent",
        "q4",
        "growth",
        "percent",
        "local",
        "currency",
        "consisted",
        "entirety",
        "organic",
        "q4",
        "income",
        "depreciation",
        "amortisation",
        "ebitda",
        "amounted",
        "sek",
        "million",
        "corresponding",
        "margin",
        "say",
        "proposes",
        "dividend",
        "sek",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "stockholm",
        "newsroom"
    ]
}